ARCHIVES

Tasigna Wins New Indication For CML; Jevtana Approved For Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 23 | June 18, 2010

Download PDF Visit The Full Archive

Related Articles

FDA Should Delay Provenge Decision Pending Definitive Trial Results, ODAC Chairman Writes.

April 27, 2007

Greenwald Says NCI Still Committed To Year 2000 Goals

January 11, 1991

John Ultmann, Chicago’s Outspoken Director, Heads In Retirement

August 30, 1991

Paul Marks To Retire As President, CEO Of Memorial Sloan-Kettering Cancer Center

December 11, 1998

Phase 1 AIDS Vaccine Trial Will Involve 81 Persons At NIH

August 28, 1987

FDA Approves Manufacturer Of IVAX Paclitaxel Ingredient.

June 29, 2001